It was personal concern that drove Anita Frauwallner from Styria to embark on a completely new path more than 30 years ago. Her interest in the medical importance of microbiome research led to the founding of the AllergoSan institute, the development of innovative products of the highest quality and the creation of the probiotic brand OMNi-BiOTiC®, which is now number 1 not only in German-speaking countries.
30 years ago it was just important to me to help people with OMNi-BiOTiC® to be able to live healthily and without restrictions, but I had no thought that this would become a global brand, says Anita Frauwallner, founder and director of the AllergoSan institute.
The success here is not only due to our excellent clinical evidence, but also the noticeable difference within a few days of use, these are the reasons why OMNi-BiOTiC® inspires so many people worldwide, adds her son Bernd Assinger, Managing Director of Institut AllergoSan.
People in over 40 countries now benefit from OMNi-BiOTiC®.
It is therefore not surprising that OMNi-BiOTiC® is already considered a benchmark in the field of probiotics in specialist circles and that the interest of potential new partners around the world continues to increase , comments Christian Gsöll, Director Business Development Institut AllergoSan, and looks forward to further expansion opportunities.
Today, the OMNi-BiOTiC® brand includes sixteen probiotics specifically formulated for different indications. These contain synergistic bacterial strains that have been carefully selected for their abilities and can colonize the human intestine. In order to massively increase the activity of these optimal intestinal dwellers, they are embedded in a matrix of enzymes and vital substances. The AllergoSan Institute is a recognized competence center for microbiome research and is known worldwide for innovative and highly effective products that have received numerous international awards, including top placements at the US NutraIngredients Award as “Probiotic of the Year”.
More than 100 research papers have already been published, 48 studies are currently ongoing and the scientific track record in high-ranking, peer-reviewed journals is excellent. This ensures the sustainable success of the OMNi-BiOTiC® brand through new developments that will continue to cause a sensation in new medical fields in the years to come. The outstanding study results in combination with excellent training concepts and a proven international marketing tool also give new sales partners the chance to quickly achieve top positions in their probiotic OTC market.
An idea was born in our country 30 years ago that has already helped millions of people who put their trust in OMNi-BiOTiC® to a noticeably better quality of life. We would like to continue working on this in order to bring many more people back to health, to give many more employees the chance to achieve excellent results at an international level with outstanding commitment, the right ideas and personal enthusiasm, sums up Anita Frauwallner, CEO Institut AllergoSan.
 IQVIA Global OTC Insights – Local Currency Eur based on Public Price, Calendar Year 2022 03F1 Probiotics Digest Health and 03D5 Antidiarrheal Micro-Organisms, IQVIA OTC audits